Liver cirrhosis
- PMID: 18328931
- PMCID: PMC2271178
- DOI: 10.1016/S0140-6736(08)60383-9
Liver cirrhosis
Abstract
Cirrhosis is defined as the histological development of regenerative nodules surrounded by fibrous bands in response to chronic liver injury, which leads to portal hypertension and end-stage liver disease. Recent advances in the understanding of the natural history and pathophysiology of cirrhosis, and in treatment of its complications, have resulted in improved management, quality of life, and life expectancy of patients. Liver transplantation remains the only curative option for a selected group of patients, but pharmacological treatments that can halt progression to decompensated cirrhosis or even reverse cirrhosis are currently being developed. This Seminar focuses on the diagnosis, complications, and management of cirrhosis, and new clinical and scientific developments.
Figures
Similar articles
-
Hepatic venous pressure gradient and outcomes in cirrhosis.J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S330-5. doi: 10.1097/MCG.0b013e318150d0f4. J Clin Gastroenterol. 2007. PMID: 17975485 Review.
-
[Hepatocellular cancer with a background of liver cirrhosis].Klin Med (Mosk). 1996;74(2):2-5. Klin Med (Mosk). 1996. PMID: 8772088 Review. Russian. No abstract available.
-
Approach to primary liver cancer.Recent Results Cancer Res. 1988;110:65-73. doi: 10.1007/978-3-642-83293-2_9. Recent Results Cancer Res. 1988. PMID: 2841728 No abstract available.
-
Health care costs associated with chronic hepatitis C virus infection in Ontario, Canada: a retrospective cohort study.CMAJ Open. 2021 Mar 8;9(1):E167-E174. doi: 10.9778/cmajo.20200162. Print 2021 Jan-Mar. CMAJ Open. 2021. PMID: 33688024 Free PMC article.
-
Treatment of HBV related cirrhosis.Liver Int. 2013 Feb;33 Suppl 1:176-81. doi: 10.1111/liv.12074. Liver Int. 2013. PMID: 23286862 Review.
Cited by
-
From Cirrhosis to the Dysbiosis (A Loop of Cure or Complications?).Indian J Microbiol. 2024 Sep;64(3):810-820. doi: 10.1007/s12088-024-01267-w. Epub 2024 Apr 3. Indian J Microbiol. 2024. PMID: 39282182 Review.
-
Real-world analysis on the use of gamma-hydroxybutyric acid for alcohol withdrawal syndrome in hospitalized patients with diagnosis of cirrhosis.Intern Emerg Med. 2024 Sep 9. doi: 10.1007/s11739-024-03761-x. Online ahead of print. Intern Emerg Med. 2024. PMID: 39249626
-
The Clinical Features and Outcomes of Pseudocirrhosis in Breast Cancer.Cancers (Basel). 2024 Aug 12;16(16):2822. doi: 10.3390/cancers16162822. Cancers (Basel). 2024. PMID: 39199595 Free PMC article.
-
Prediction models for differentiating benign from malignant liver lesions based on multiparametric dual-energy non-contrast CT.Eur Radiol. 2024 Aug 26. doi: 10.1007/s00330-024-11024-8. Online ahead of print. Eur Radiol. 2024. PMID: 39186105
-
Association between serum vitamin D status and severity of liver cirrhosis: implications for therapeutic targeting in Nigerian patients.BMC Gastroenterol. 2024 Aug 12;24(1):259. doi: 10.1186/s12876-024-03353-1. BMC Gastroenterol. 2024. PMID: 39135191 Free PMC article.
References
-
- Bircher J, Benhamou JP, McIntyre N, Rizzetto M, Rodes J, editors. Oxford Textbook of Clinical Hepatology. 2nd Edition Oxford University Press; 1999.
-
- Sherlock S, Dooley J, editors. Diseases of the Liver and Biliary System. 11th Edition Blackwell Science; Oxford, UK; Malden, MA: 2002.
-
- Schiff ER, Sorrell MF, Maddrey EC, editors. Schiff’s Diseases of the Liver. 9th Edition Lippincott, Williams & Wilkins; Philadelphia: 2003.
-
- Schaffner H, Popper H. Capillarization of the sinusoids. Gastroenterology. 1963;44:339–42.
-
- Desmet VJ, Roskams T. Cirrhosis reversal: a duel between dogma and myth. J Hepatol. 2004;40:860–7. - PubMed
Publication types
MeSH terms
Grants and funding
- U19 AI066313-049001/AI/NIAID NIH HHS/United States
- U19 A1 066313/PHS HHS/United States
- U19 AI066313-040003/AI/NIAID NIH HHS/United States
- U19 AI066313-019001/AI/NIAID NIH HHS/United States
- U19 AI066313-010003/AI/NIAID NIH HHS/United States
- U01 AT003571-02/AT/NCCIH NIH HHS/United States
- U19 AI066313-029001/AI/NIAID NIH HHS/United States
- U01 AT003571/AT/NCCIH NIH HHS/United States
- U19 AI066313-039001/AI/NIAID NIH HHS/United States
- U01 AT003571-01/AT/NCCIH NIH HHS/United States
- 1 R21 DK076873-01A1/DK/NIDDK NIH HHS/United States
- U19 AI066313-030003/AI/NIAID NIH HHS/United States
- R21 DK076873-01A1/DK/NIDDK NIH HHS/United States
- U19 AI066313-020003/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical